A Tiny Biotech Just Posted 10× Stronger Cancer Results
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
About Fulcrum Therapeutics Inc
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers drug targets for potential treatment inherited aplastic anemias, such as of diamond-blackfan anemia, shwachman-diamond syndrome, and fanconi anemia, as well as novel fetal hemoglobin inducers, fibrotic disorders, and cardiomyopathies which is in preclinical trial. It has collaboration and license agreement with MyoKardia, Inc. to identify biological targets that are capable of modulating genes of interest with relevance to cardiomyopathies; and licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize; and Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
General
| Name | Fulcrum Therapeutics Inc |
| Ticker | FULC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 45 |
Highlights
| Analyst Target | 13.00 |
| Market Cap | 453,000,000 |
| EBITDA | -80,093,000 |
Share Stats
| Shares Outstanding | 54,110,000 |
| Shares Float | 47,970,000 |
| Shares Short | 3,550,000 |
| Insider Holdings | 153% |
| Institution Holdings | 101.52% |
Highlights
| Analyst Target | 13.00 |
| Market Cap | 453,000,000 |
| EBITDA | -80,093,000 |
Valuation
| Price/Sales (Trailing 12 Mt.) | 5.12 |
| Price/Book (Most Recent Quarter) | 2.40 |
Earnings
Five 2026 vehicles you should absolutely wait for
Don’t buy that new car yet. If you can wait, you’ll have new 2026 model year options that aren’t out yet. Although some models barely change, others are completely redesigned and often get the latest features and improvements. Whether you’re interested in improved fuel economy, cutting-edge technology, or maybe just fresh and distinctive styling, there’s likely a car on the horizon that you’ll be interested in. To ensure you don’t miss out on the latest and greatest, the car experts at Edmunds highlight five vehicles you should consider waiting for.
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Warren Buffett's Berkshire Hathaway Bets Big On Consumer Brands Amid Economic Shifts
Warren Buffett and his successor Greg Abel have been directing Berkshire Hathaway towards consumer-centric investments throughout 2025.
Stability AI largely wins UK court battle against Getty Images over copyright and trademark
LONDON (AP) — Artificial intelligence company Stability AI mostly prevailed against Getty Images Tuesday in a British .
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
S&P Global Boosts Outlook As CEO Hails Exceptional Growth
S&P Global (NYSE: SPGI) shares surge after reporting strong Q3 results, beating expectations with adjusted earnings of $4.73 per share.
Ford's enormous F-150 becomes unlikely part of Japan's efforts to woo Trump
TOKYO (AP) — Japan's most iconic truck might be the tiny white transport vehicles that farmers use to lug gear on the narrow roads that link their rice fields.
Why Are 21 Billionaires Moving Their Money ASAP? - Ad
One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.
Warner Bros., Ford, General Motors Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 20-Oct. 24): Are the Others in Your Portfolio?
Top large-cap gainers last week include SNDK, CRS, PEGA, ISRG, GM, HAL, FIX, WBD, LVS, F on earnings, upgrades, auctions.
Energy Fuels (UUUU) Stock Is Rising Tuesday: What's Fueling The Surge?
Energy Fuels shares are trading higher on Tuesday alongside Cameco Corp, which announced a strategic partnership with the U.S. government.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Consumer Tech News (Oct 27-31): Nvidia Surpasses $5T Market Cap, Trump-Xi Meeting Concludes, Big Tech Report Earnings & More
Apple, Amazon, Microsoft, and Alphabet beat Q3 estimates with revenue and earnings growth. Trump and Xi conclude high-stakes meeting with trade, soybean, and resource agreements, potentially impacting U.S.-China economic relations and global markets.
Social Security Faces Insolvency In 7 Years — Committee Proposes COLA Cap For Wealthier Retirees
Proposal to limit Social Security COLAs for high earners aims to prevent insolvency. Checks may increase by 2.8% in 2026.
Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
After winning Trump's $20 billion, President Milei must win votes as Argentine industry reels
BUENOS AIRES, Argentina (AP) — The factory floor used to roar.
Trump says a Canadian ad misstated Ronald Reagan's views on tariffs. Here are the facts and context
WASHINGTON (AP) — President Donald Trump pulled out of trade talks with Canada Thursday night, furious over what he called a “fake’’ television ad from Ontario’s provincial government that quoted former U.S. President Ronald Reagan from 38 years ago criticizing tariffs -- Trump’s favorite economic tool.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs
Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.
Trump Reportedly Rebuffs Ukraine Missile Appeal After Putin Call: 'Time To Stop...'
President Donald Trump declined to supply Ukraine with Tomahawk missiles after a tense meeting with Ukrainian President Volodymyr Zelensky at the White House on Friday, according to a report.
New Number One Copper Start Alert - Ad
EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.
Donald Trump Faces 'No Kings Day' Protests As Millions March Nationwide, GOP Stays Silent Amid Authoritarianism Claims
Millions rallied nationwide against Trump, with top lawmakers supporting protests and condemning Trump's consolidation of power.
Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks
Here's a look at the most heavily shorted stocks in the market as investors look for the next Beyond Meat.
Chamath Palihapitiya Sees Current Tech Giants Having An Upper Hand In AI Wars: 'Google Has A Huge Runway'
Chamath Palihapitiya says incumbents will win the AI race, arguing Google's "huge runway" and "massive distribution" gives it the edge.
Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad
You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1
Chipotle Vs. Wingstop: Analyst Flags Income, Diversity Gaps
Wingstop's less affluent customer base may face short-term pressure; whereas Chipotle has pricing flexibility.
3 Communication Stocks Making Big Moves On Value Metrics
Three communication service stocks posted sharp gains in Benzinga's value rankings this week, highlighting renewed investor interest in the sector. Here's what investors need to know.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Maye Musk Says She Only 'Lasted' Until 11 PM At Elon's Saturday Meetings, Agrees With Trump's AI Czar No One Works Harder Than Her Son
Maye Musk shares insights into Elon Musk's work habits, emphasizing his dedication. She could only last until 11 PM in his Saturday meetings.
IonQ, D-Wave Quantum, Rigetti Computing Surge Over 11% Pre-Market: What's Going On?
Shares of IonQ Inc. (NYSE: IONQ), Rigetti Computing (NASDAQ: RGTI), and D-Wave Quantum (NYSE: QBTS) surged in premarket trading on Thursday.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Dogecoin's $0.21 Problem: Why This Analyst Says Keep It On Your Radar
On Monday, social media influencer Ali Martinez, known popularly on X as Ali, drew the attention of the crypto community to an important resistance level for Dogecoin (CRYPTO: DOGE).
How To Earn $500 A Month From UnitedHealth Group Stock Ahead Of Q3 Earnings
UNH to release Q3 earnings before opening bell on Tuesday. Analysts predict $2.81/share, down from $7.15/share in 2019. Dividend yield at 2.44%.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Chinese leader Xi Jinping outlines 5-year plan at closed-door Communist Party meeting
BEIJING (AP) — Chinese leader Xi Jinping delivered a speech Monday on the opening day of of the ruling Communist Party to approve a draft plan laying out its goals for the country over the next five years.
Faulty engineering led to implosion of Titan submersible headed to Titanic wreckage, NTSB finds
PORTLAND, Maine (AP) — Faulty engineering led to the implosion of an experimental submersible that killed five people on the way to the wreck of the , the National Transportation Safety Board concluded in a report Wednesday.
Why Are 21 Billionaires Moving Their Money ASAP? - Ad
One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.
Supreme Court will consider whether people who regularly smoke pot can legally own guns
WASHINGTON (AP) — said on Monday that it will consider whether people who regularly smoke marijuana can legally own guns, the latest firearm case to come before the court since .
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.